Notes to the Financial Statements (Company)
5 Reconciliation of movement in shareholders' funds
| |
2008 $m |
2007 (restated) $m |
|---|---|---|
| At beginning of year, as previously reported | 22,222 | 19,446 |
| Prior year adjustment – UITF 44 | 724 | 569 |
| Restated at beginning of year | 22,946 | 20,015 |
| Net profit for the financial year | 3,436 | 9,407 |
| Dividends | (2,767) | (2,658) |
| Gain/(loss) on cash flow hedge in anticipation of debt issue | 1 | (21) |
| Share-based payment | 178 | 155 |
| Issue of AstraZeneca PLC Ordinary Shares | 159 | 218 |
| Re-purchase of AstraZeneca PLC Ordinary Shares | (610) | (4,170) |
| Net increase in shareholders’ funds | 397 | 2,931 |
| Shareholders’ funds at end of year | 23,343 | 22,946 |
Details of dividends paid and payable to shareholders are given in Note 21 to the Consolidated Financial Statements.
DOWNLOAD REPORT
Our report is available to download in either CORPORATE RESPONSIBILITY
Find out more about our commitment to responsible business
GLOSSARY
Abbreviations/expressions and their meanings, when used on this website
FEEDBACK
Your opinions and comments are very important to us
